Improved Mitochondrial Function Underlies the Protective Effect of Pirfenidone against Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats

Dysfunctional mitochondria participate in the progression of chronic kidney disease (CKD). Pirfenidone is a newly identified anti-fibrotic drug. However, its mechanism remains unclear. Mitochondrial dysfunction is an early event that occurs prior to the onset of renal fibrosis. In this context, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun-Feng, Liu, Hong, Ni, Hai-Feng, Lv, Lin-Li, Zhang, Ming-Hui, Zhang, Ai-Hua, Tang, Ri-Ning, Chen, Ping-Sheng, Liu, Bi-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857290/
https://www.ncbi.nlm.nih.gov/pubmed/24349535
http://dx.doi.org/10.1371/journal.pone.0083593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857290/
https://www.ncbi.nlm.nih.gov/pubmed/24349535
http://dx.doi.org/10.1371/journal.pone.0083593

Ejemplares similares